alternatives to glp 1 drugs GLP-1 for Employers GLP-1 Drug Comparison in Diabetes

You deserve clarity before you start

The main risk associated with GHK-Cu in clinical practice is sourcing quality, unregulated compounding pharmacies or unverified online vendors may produce peptide preparations with impurities that cause reactions incorrectly attributed to the peptide itself

The Bottom Line GHK-Cu sits in a strange spot in the peptide research world genuinely old research (Pickart's earliest work goes back to the 1970s), genuinely broad mechanistic reach (thousands of modulated genes), but still a compound where the human clinical trial base lags behind the mechanistic and cell-culture data

Returning to an opened saline vial for a second draw is a contamination risk every time, regardless of how quickly you work